N72482AT4
Qiagen N.v.
Could not find a ticker for this position, may be a filing error
A maker of kits and instruments that extract, purify, and analyze DNA, RNA, and proteins from biological samples, QIAGEN's "Sample to Insight" products are used by research labs, hospitals, and forensic scientists around the world. Founded in 1984 in Düsseldorf, Germany, as Diagen by three doctoral students and their professor, it was one of the first biotech spin-offs from a German university. The "Q" in its name comes from "Q-Smaragd," the special resin in its first plasmid-purification kits.
CONVERTIBLEUnderlying: QGENCINS: N72482AT4HealthcareNL1 derivative reporter
2.5% Convertible Bonds due 2031
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
